Antikoagulation im Alter
Authors:
- J. HarenbergJHJ. Harenberg
- R. BauersachsRBR. Bauersachs
- C. DiehmCDC. Diehm
- H. LawallHLH. Lawall
- H. BurkhardtHBH. Burkhardt
- H. GerlachHGH. Gerlach
- H. DariusHDH. Darius
- H. VöllerHVH. Völler
- E. RabeERE. Rabe
- M. WehlingMWM. Wehling
- 24 November 2010
- journal article
- abstracts
- Published by Springer Nature in Die Innere Medizin
- Vol. 51 (11) , 1446-1455
Abstract
The recommendations for anticoagulation in over 80 years old patients are based on the thromboembolic/bleeding risk relation. They add to the published recommendations for the specific indications. Low-molecular-weight heparin (LMWH) is used to prevent thromboembolism postoperatively. Compression stockings and/or intermittent pneumatic compression are used if bleeding risk is very high. The dose is increased starting at day two if the thromboembolic risk is very high. Bleeding and thromboembolic risks are re-evaluted daily. The antithrombotic therapy is adjusted accordingly. Prophylaxis of thromboembolism in patients with acute illnesses and bedrest is performed according postoperative care. Two-thirds of therapeutic doses of low-molecular-weight heparin are used to treat acute venous thromboembolism. Reduced renal function (creatinine clearance <30 ml/ min for most LMWHs or <20 ml/min for tinzaparin) should result in a further reduction of dose. Intensity and duration of prophylaxis of recurrent events with vitamin K antagonist or LMWH in malignancy follow current or herein described recommendations. Patients with atrial fibrillation are treated with vitamin K antagonists adjusted to an INR of 2-3 for prophylaxis of embolism. Further details of anticoagulant therapy should be in agreement with the national or international recommendations.Keywords
This publication has 56 references indexed in Scilit:
- Reasons for Undertreatment with Oral Anticoagulants in Frail Geriatric Outpatients with Atrial FibrillationDrugs & Aging, 2010
- Stroke risk in atrial fibrillation patients on warfarinThrombosis and Haemostasis, 2009
- Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practicePalliative Medicine, 2008
- Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapyCanadian Medical Association Journal, 2008
- Pharmacology and Management of the Vitamin K AntagonistsChest, 2008
- Don’t add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulationBMJ, 2008
- Bleeding risks with combination of oral anticoagulation plus antiplatelet therapy: Is clopidogrel any safer than aspirin when combined with warfarin?Thrombosis and Haemostasis, 2008
- Death and Disability from Warfarin-Associated Intracranial and Extracranial HemorrhagesThe American Journal of Medicine, 2007
- Age and the Risk of Warfarin‐Associated Hemorrhage: The Anticoagulation and Risk Factors In Atrial Fibrillation StudyJournal of the American Geriatrics Society, 2006
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976